Leadless cardiac pacing systems: current status and future prospects.

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Technology

Background:

• Transvenous pacemaker therapy is standard for symptomatic bradyarrhythmias but carries risks.
• Leadless pacemaker therapy offers a potential solution to lead- and pocket-related complications.
• The technology has evolved since its inception in 2012, with numerous studies evaluating its use.

Purpose of the Study:

• To review the current status of leadless pacemaker technology.
• To evaluate safety, efficacy, indications, and end-of-life management of leadless pacemakers.
• To discuss future perspectives and novel pacing modalities.

Main Methods:

• Comprehensive literature review of studies on leadless pacemaker technology.
• Analysis of safety and efficacy data from clinical trials and real-world studies.
• Evaluation of current indications and end-of-life management strategies.

Main Results:

• First-generation leadless pacemakers provide safe and effective single-chamber pacing.
• Limitations include end-of-life management and single-chamber indication.
• Ongoing innovations aim to overcome these limitations.

Conclusions:

• Leadless pacemakers are a promising innovation for bradyarrhythmia management.
• Further advancements are needed for broader clinical implementation.
• Future developments may revolutionize cardiac pacing therapy.